| VBIV Market Cap History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the VBIV market cap history going back to 5/2/2016:
Also see: VBIV Shares Outstanding History and VBIV YTD Return |
As of 5/15/2024 VBI Vaccines has a market cap of 18.93 million. Investors often follow the VBIV market cap history to compare the size of the company over time.
This page shows VBIV market capitalization trends over time, with 31 market cap datapoints presented, dating back to 5/2/2016.

| VBIV Market Cap History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the VBIV market cap history going back to 5/2/2016:
Also see: VBIV Shares Outstanding History and VBIV YTD Return |
| VBIV Market Cap History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
VBIV Historical Market Cap: -9.63% CAGR
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| VBIV Stock Price Chart |
| About VBI Vaccines Inc (Canada) |
| VBI Vaccines is a biopharmaceutical company. Co. develops vaccine candidates that mimic the natural presentation of viruses. Co.'s pipeline is comprised of vaccine and immunotherapeutic candidates developed by virus-like particle technologies to target two disease areas, infectious disease and oncology. Co.'s prophylactic candidates are 3-antigen Vaccine for the indication of Hepatitis B (HBV), VBI-1501 for the indication of Cytomegalovirus (CMV), VBI-2901 for the indication of Pan-coronavirus, and VBI-2902 for the indication of COVID-19. Co.'s therapeutic candidates are VBI-2601 for the indication of HBV and VBI-1901 for the indication of Glioblastoma plus other CMV-Associated Cancers. We show 31 historical shares outstanding datapoints in our VBIV shares outstanding history coverage, used to compute VBIV market cap on those dates. Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing VBIV market cap history over the course of time is important for investors interested in comparing VBIV's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of VBIV versus a peer is one thing; comparing VBIV market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like VBIV can fluctuate over the course of history. With this page we aim to empower investors researching VBIV by allowing them to research the VBIV market cap history. |
| VBIV Current Stock Quote |
Quotes delayed 20 minutes Get Dividend Alerts Get SEC Filing Alerts |
| Video: The Importance of Market Cap | |
|
| VBIV Share Performance |
| Market Cap Peers |
| VBI Vaccines (VBIV) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:
VCEL Market Cap History VCNX Market Cap History VCYT Market Cap History VERA Market Cap History VERO Market Cap History VERU Market Cap History VERV Market Cap History VICL Market Cap History VIE Market Cap History VIGL Market Cap History More Healthcare companies » |
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.2%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.2%.